Tyler presented his work to develop an AAV-CRISPR/Cas9- based therapy for autosomal dominant CORD6 at this week’s College of Medicine Biomedical Sciences seminar series. Despite looking somewhat sad to be discussing phototransduction here, he was actually quite excited! 